Compass Therapeutics to Participate in Upcoming September Investor Events
Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology biopharmaceutical company, has announced its participation in four major investor conferences in September 2025:
- Citi's Biopharma Back to School Conference in Boston (Sept 2)
- Cantor Global Healthcare Conference in New York (Sept 3, 2:10 PM ET)
- H.C. Wainwright Global Investment Conference in New York (Sept 8, 11 AM ET)
- Morgan Stanley Global Healthcare Conference in New York (Sept 9, 5:35 PM ET)
All presentations will be archived for 90 days on Compass' Events page.
Compass Therapeutics (Nasdaq: CMPX), società biofarmaceutica oncologica in fase clinica, ha comunicato la sua partecipazione a quattro importanti conferenze per investitori a settembre 2025:
- Citi's Biopharma Back to School Conference a Boston (2 settembre)
- Cantor Global Healthcare Conference a New York (3 settembre, 14:10 ET)
- H.C. Wainwright Global Investment Conference a New York (8 settembre, 11:00 ET)
- Morgan Stanley Global Healthcare Conference a New York (9 settembre, 17:35 ET)
Tutte le presentazioni saranno archiviate per 90 giorni nella pagina Eventi di Compass.
Compass Therapeutics (Nasdaq: CMPX), compañía biofarmacéutica oncológica en fase clínica, ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025:
- Citi's Biopharma Back to School Conference en Boston (2 de septiembre)
- Cantor Global Healthcare Conference en Nueva York (3 de septiembre, 14:10 ET)
- H.C. Wainwright Global Investment Conference en Nueva York (8 de septiembre, 11:00 ET)
- Morgan Stanley Global Healthcare Conference en Nueva York (9 de septiembre, 17:35 ET)
Todas las presentaciones estarán archivadas durante 90 días en la página de Eventos de Compass.
Compass Therapeutics (Nasdaq: CMPX), 임상 단계의 종양학 바이오제약 기업은 2025년 9월에 개최되는 네 곳의 주요 투자자 컨퍼런스에 참가한다고 발표했습니다:
- Citi's Biopharma Back to School Conference, 보스턴 (9월 2일)
- Cantor Global Healthcare Conference, 뉴욕 (9월 3일, 동부시간 오후 2시10분)
- H.C. Wainwright Global Investment Conference, 뉴욕 (9월 8일, 동부시간 오전 11시)
- Morgan Stanley Global Healthcare Conference, 뉴욕 (9월 9일, 동부시간 오후 5시35분)
모든 발표 자료는 Compass 이벤트 페이지에 90일 동안 보관됩니다.
Compass Therapeutics (Nasdaq: CMPX), entreprise bio‑pharmaceutique en oncologie en phase clinique, a annoncé sa participation à quatre grandes conférences investisseurs en septembre 2025 :
- Citi's Biopharma Back to School Conference à Boston (2 septembre)
- Cantor Global Healthcare Conference à New York (3 septembre, 14h10 ET)
- H.C. Wainwright Global Investment Conference à New York (8 septembre, 11h00 ET)
- Morgan Stanley Global Healthcare Conference à New York (9 septembre, 17h35 ET)
Toutes les présentations seront archivées pendant 90 jours sur la page Événements de Compass.
Compass Therapeutics (Nasdaq: CMPX), ein klinisch fortgeschrittenes Onkologie-Biopharmaunternehmen, hat seine Teilnahme an vier großen Investorenkonferenzen im September 2025 angekündigt:
- Citi's Biopharma Back to School Conference in Boston (2. Sept.)
- Cantor Global Healthcare Conference in New York (3. Sept., 14:10 ET)
- H.C. Wainwright Global Investment Conference in New York (8. Sept., 11:00 ET)
- Morgan Stanley Global Healthcare Conference in New York (9. Sept., 17:35 ET)
Alle Präsentationen werden für 90 Tage auf der Veranstaltungsseite von Compass archiviert.
- None.
- None.
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September.
Details are as follows:
Citi’s 2025 Biopharma Back to School Conference
Location: Boston, MA
Date: Tuesday, September 2, 2025
Cantor Global Healthcare Conference
Location: New York, NY
Date: Wednesday, September 3, 2025
Time: 2:10 PM ET
Webcast Link: https://cmpx.info/cantor
H.C. Wainwright 27th Annual Global Investment Conference
Location: New York, NY
Date: Monday, September 8, 2025
Time: 11 AM ET
Webcast Link: https://journey.ct.events/view/c21a88e1-14c6-46cd-85b8-dbfa550d85a1
Morgan Stanley 23rd Annual Global Healthcare Conference
Location: New York, NY
Date: Tuesday, September 9, 2025
Time: 5:35 PM ET
Webcast Link: https://cc.webcasts.com/morg007/090825a_js/?entity=89_N2MHE8Q
Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com
617-500-8099
